Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

NIH

National Institutes of Health

  • your selections
Clear Search

Filter Results

date

Area

Information Type

Organization/Initiative

Issue/Condition

  • results
U.S. signs agreement creating the Global Alliance for Chronic Diseases

The National Heart, Lung, and Blood Institute (NHLBI) and the Fogarty International Center, both of the National Institutes of Health (NIH), join similar agencies from Australia, Canada, China, and the U.K. to create the Global Alliance for Chronic Diseases (GACD), “the first collaboration of major research funding agencies to address the specific needs of chronic noncommunicable diseases.” The GACD “plans to facilitate collaborative funding activities for innovative, original research directed at the prevention and treatment of chronic diseases” and will focus “on the needs of low and middle income countries, and on those of low income populations of more developed countries.”

NHLBI funds research and training centers aimed at prevention and treatment of chronic diseases in developing countries

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), announced an effort to create “a worldwide network of research and training centers [that] will build institutional and community capacity to prevent and control chronic diseases, such as cardiovascular, lung diseases, and diabetes.” The NHLBI will be awarding a total of $34 million in 10 contracts to establish a worldwide network of partnerships “led by a research institution in a low- or middle-income developing country paired with at least one partner academic institution in a developed country to enhance research and training opportunities.”

NIH Announces New Program to Develop Therapeutics for Rare and Neglected Diseases

The National Institutes of Health (NIH) launched a new drug development initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND. Initiated with $24 million in funding, the program is dedicated to producing new treatments for rare and neglected diseases.

Recovery Act provides funding to schools for global health studies programs

As part of the American Recovery and Reinvestment Act, the Fogarty International Center at the National Institutes of Health (NIH) will receive funds to support the “Framework Program for Global Health” (FRAME), which provides grants to schools that “develop multidisciplinary Global Health curricula for undergraduate, graduate and professional school students.”

NIH Directors release joint statement in observance of World Asthma Day

On World Asthma Day, the three directors of the National Institute of Allergy and Infectious Diseases (NIAID), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Environmental Health Sciences (NIEHS) released a joint statement stating that they “stand together with the international community to renew our dedication to understand the causes of asthma and to find better ways to treat, prevent and manage this disease.”

Fogarty International Center awards $2.7 million in AIDS training grants in 15 countries

The Fogarty International Center of the National Institutes of Health (NIH) awarded grants totaling almost $2.7 million to train HIV/AIDS researchers in 15 low- and middle-income countries. The grants were awarded as part of the 20-year-old AIDS International Training and Research Program (AITRP).